HCPCS code J8522 — Capecitabine, oral, 50 mg. Status: Active. Effective Jan 1, 2025. Source: CMS HCPCS Level II.

J8522

Active

Capecitabine, oral, 50 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2025
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 0804

MUE — Medically Unlikely Edits

Maximum units of J8522 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 150

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00004-1100-20 Xeloda
00004-1101-50 Capecitabine
00093-7473-06 Capecitabine
00093-7474-89 Capecitabine
16714-0467-01 Capecitabine
16714-0468-01 Capecitabine
16729-0072-12 Capecitabine
16729-0073-29 Capecitabine
55111-0496-60 Capecitabine
55111-0497-04 Capecitabine
59651-0204-60 Capecitabine
59651-0205-08 Capecitabine
60687-0149-94 Capecitabine
61269-0470-60 Xeloda
67877-0458-60 Capecitabine
67877-0459-12 Capecitabine
68001-0487-06 Capecitabine
68001-0488-07 Capecitabine
68001-0643-06 Capecitabine
68001-0644-07 Capecitabine

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q1
    Capecitabine, oral, 50 mg